EGFR-targeting antitumor therapy: Neuregulins or antibodies?

  1. de Lavera, I.
  2. Merkling, P.J.
  3. Oliva, J.M.
  4. Sayagués, M.J.
  5. Cotán, D.
  6. Sánchez-Alcázar, J.A.
  7. Infante, J.J.
  8. Zaderenko, A.P.
Revue:
European Journal of Pharmaceutical Sciences

ISSN: 1879-0720 0928-0987

Année de publication: 2021

Volumen: 158

Type: Article

DOI: 10.1016/J.EJPS.2020.105678 GOOGLE SCHOLAR

Objectifs de Développement Durable